Vizora日本語

Taiko PharmaceuticalTAIKO PHARMACEUTICAL CO., LTD.4574東証プライム医薬品FY ending Dec 2025, consolidated, J-GAAP

Taiko Pharmaceutical FY ending Dec 2021 results

About 61% of Taiko Pharmaceutical's sales come from Infection Control Business, with Pharmaceuticals Business making up much of the rest.

It lost about ¥44 for every ¥100 of sales at the operating level.

Revenue changed -35.7% from the prior year, operating profit -187.6%.

What changed from last year

FY ending Dec 2020 → FY ending Dec 2021

Revenue
-35.7%¥17.6B → ¥11.3B
Gross profit
-73.0%¥12.3B → ¥3.33B
Operating income
-187.6%¥5.65B → -¥4.95B
Net income attributable to owners
-349.1%¥3.85B → -¥9.59B
Operating cash flow
Loss-¥1.52B → -¥1.59B
Free cash flow
Loss-¥3.74B → -¥3.19B

Where the money goes

FY ending Dec 2020 → FY ending Dec 2021

Where ¥100 of sales goes

For every ¥100 Taiko Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Dec 2021
Cost of sales
¥71
SG&A
¥68
Other costs
¥5
Operating loss
¥44
Net loss
¥85

Annual margin trends

Gross margin29.4%
FY ending Mar 2020: 70.9%70.9%FY ending Dec 2020: 70.1%70.1%FY ending Dec 2021: 29.4%29.4%FY20FY20FY21
Operating margin-43.8%
FY ending Mar 2020: 25.6%25.6%FY ending Dec 2020: 32.1%32.1%FY ending Dec 2021: -43.8%-43.8%FY20FY20FY21
Net margin-84.9%
FY ending Mar 2020: 16.4%16.4%FY ending Dec 2020: 21.9%21.9%FY ending Dec 2021: -84.9%-84.9%FY20FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2021

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第80期(2025/01/01－2025/12/31)

    ID S100XSJ22026-03-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第79期(2024/01/01－2024/12/31)

    ID S100VHKD2025-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第78期(2023/01/01－2023/12/31)

    ID S100T5112024-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第77期(2022/01/01－2022/12/31)

    ID S100QI1S2023-03-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第76期(令和3年1月1日－令和3年12月31日)

    ID S100NS202022-03-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第75期(令和2年4月1日－令和2年12月31日)

    ID S100L2I22021-03-30Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image